Cargando…
Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease
Accumulation of misfolded proteins is a common phenomenon of several neurodegenerative diseases. The misfolding of proteins due to abnormal polyglutamine (PolyQ) expansions are linked to the development of PolyQ diseases including Huntington’s disease (HD). Though the genetic basis of PolyQ repeats...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775980/ https://www.ncbi.nlm.nih.gov/pubmed/35054963 http://dx.doi.org/10.3390/ijms23020780 |
_version_ | 1784636719879946240 |
---|---|
author | Maity, Shuvadeep Komal, Pragya Kumar, Vaishali Saxena, Anshika Tungekar, Ayesha Chandrasekar, Vaani |
author_facet | Maity, Shuvadeep Komal, Pragya Kumar, Vaishali Saxena, Anshika Tungekar, Ayesha Chandrasekar, Vaani |
author_sort | Maity, Shuvadeep |
collection | PubMed |
description | Accumulation of misfolded proteins is a common phenomenon of several neurodegenerative diseases. The misfolding of proteins due to abnormal polyglutamine (PolyQ) expansions are linked to the development of PolyQ diseases including Huntington’s disease (HD). Though the genetic basis of PolyQ repeats in HD remains prominent, the primary molecular basis mediated by PolyQ toxicity remains elusive. Accumulation of misfolded proteins in the ER or disruption of ER homeostasis causes ER stress and activates an evolutionarily conserved pathway called Unfolded protein response (UPR). Protein homeostasis disruption at organelle level involving UPR or ER stress response pathways are found to be linked to HD. Due to dynamic intricate connections between ER and mitochondria, proteins at ER-mitochondria contact sites (mitochondria associated ER membranes or MAMs) play a significant role in HD development. The current review aims at highlighting the most updated information about different UPR pathways and their involvement in HD disease progression. Moreover, the role of MAMs in HD progression has also been discussed. In the end, the review has focused on the therapeutic interventions responsible for ameliorating diseased states via modulating either ER stress response proteins or modulating the expression of ER-mitochondrial contact proteins. |
format | Online Article Text |
id | pubmed-8775980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87759802022-01-21 Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease Maity, Shuvadeep Komal, Pragya Kumar, Vaishali Saxena, Anshika Tungekar, Ayesha Chandrasekar, Vaani Int J Mol Sci Review Accumulation of misfolded proteins is a common phenomenon of several neurodegenerative diseases. The misfolding of proteins due to abnormal polyglutamine (PolyQ) expansions are linked to the development of PolyQ diseases including Huntington’s disease (HD). Though the genetic basis of PolyQ repeats in HD remains prominent, the primary molecular basis mediated by PolyQ toxicity remains elusive. Accumulation of misfolded proteins in the ER or disruption of ER homeostasis causes ER stress and activates an evolutionarily conserved pathway called Unfolded protein response (UPR). Protein homeostasis disruption at organelle level involving UPR or ER stress response pathways are found to be linked to HD. Due to dynamic intricate connections between ER and mitochondria, proteins at ER-mitochondria contact sites (mitochondria associated ER membranes or MAMs) play a significant role in HD development. The current review aims at highlighting the most updated information about different UPR pathways and their involvement in HD disease progression. Moreover, the role of MAMs in HD progression has also been discussed. In the end, the review has focused on the therapeutic interventions responsible for ameliorating diseased states via modulating either ER stress response proteins or modulating the expression of ER-mitochondrial contact proteins. MDPI 2022-01-11 /pmc/articles/PMC8775980/ /pubmed/35054963 http://dx.doi.org/10.3390/ijms23020780 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Maity, Shuvadeep Komal, Pragya Kumar, Vaishali Saxena, Anshika Tungekar, Ayesha Chandrasekar, Vaani Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title | Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title_full | Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title_fullStr | Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title_full_unstemmed | Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title_short | Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease |
title_sort | impact of er stress and er-mitochondrial crosstalk in huntington’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775980/ https://www.ncbi.nlm.nih.gov/pubmed/35054963 http://dx.doi.org/10.3390/ijms23020780 |
work_keys_str_mv | AT maityshuvadeep impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease AT komalpragya impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease AT kumarvaishali impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease AT saxenaanshika impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease AT tungekarayesha impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease AT chandrasekarvaani impactoferstressandermitochondrialcrosstalkinhuntingtonsdisease |